Closing Bell: Hls Therapeutics Inc down on Thursday (HLS)

In market activity today, Hls Therapeutics Inc stock opened at $3.45 and closed at $3.20. prices ranged from a low of $3.18 to a high of $3.50.

The price eased -7.25 percent from the previous day's close of $3.45.

Today across North America, the TSX Composite closed -0.54% at 22726.76, the S&P 500 closed -1.39% at 5588.27, the Dow Jones Industrial Average closed 0.59% at 41198.08 and the Nasdaq Composite closed -2.77% at 17996.92.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

Trading volume was 2,305 on 19 total trades. On average, Hls Therapeutics Inc has traded 1,626 shares over the last 5-days and 7,474 year-to-date.

The TSX overall saw 1,017 price advancers against 4,222 declines and 91 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.54 (July 21,2023) and low as $3.18 (July 18,2024). Moreover, in the last 12 months, Hls Therapeutics Inc's shares have shrunken -50.69 percent, while they have slid -18.99% year-to-date.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $109.76 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Hls Therapeutics Inc's average recommendation is "Moderate Buy" based on 5.00 analysts according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..